On the subject line, please specify if your abstract is an original, encore or late-breaking abstract.
Please specify which topic are you submitting on the email body:
a. Works related to broad areas of rheumatic & musculoskeletal disorders (RMDs)
b. Autoimmune and inflammatory Manifestations of COVID-19
All abstracts must be submitted and presented in English.
You abstract should be structured in different sections such as:
e. Acknowledgements (if applicable) and References.
Abstracts may not be longer than 3500 characters including spaces.
Corrections to abstracts can only be made until the deadline Monday, 15 August 2022
The notification of acceptance/rejection of the abstracts will be sent to you via email by the week of 12 September 2022.